PHARMA EVIDENCE ApS — Credit Rating and Financial Key Figures

CVR number: 34586519
Sommervej 9, 3520 Farum

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit1 076.24196.01551.99- 428.46- 157.71
Employee benefit expenses- 238.22- 644.20- 411.88- 381.16-27.25
EBIT838.01- 448.19140.10- 809.62- 184.95
Other financial income5.9111.8810.6122.6316.64
Other financial expenses-15.68-6.18-16.00-12.46-11.44
Pre-tax profit828.24- 442.48134.71- 799.45- 179.75
Income taxes- 184.9162.653.34
Net earnings643.33- 442.48197.36- 796.11- 179.75

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total-0.00
Non-current other receivables364.6885.46
Long term receivables total364.6885.46
Inventories total
Current trade debtors1 394.80937.45898.53671.28155.00
Current amounts owed by group member comp.69.24
Current other receivables266.62267.070.000.0653.61
Current deferred tax assets3.34
Short term receivables total1 730.661 204.53898.54674.69208.61
Cash and bank deposits119.73115.224.6823.363.15
Cash and cash equivalents119.73115.224.6823.363.15
Balance sheet total (assets)1 850.391 319.751 267.90783.51211.77

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital80.0080.0080.0080.0080.00
Retained earnings569.901 213.23770.75968.11172.00
Profit of the financial year643.33- 442.48197.36- 796.11- 179.75
Shareholders equity total1 293.23850.751 048.11252.0072.25
Provisions0.00
Non-current liabilities total
Current loans from credit institutions0.900.9510.40
Current trade creditors15.0015.0015.00216.0015.00
Current owed to group member110.2860.00121.05122.42
Short-term deferred tax liabilities184.9115.36
Other non-interest bearing current liabilities356.34342.77119.03194.462.09
Current liabilities total557.15469.00219.79531.50139.51
Balance sheet total (liabilities)1 850.391 319.751 267.90783.51211.77
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.